TET2 and leukemia: TET1, an ortholog of TET2, catalyses the conversion of 5-methylcytosine (5mC) in DNA to 5-hydroxymethylcytosine (hmC) (3), which suggests that epigenetic regulation plays a critical role in leukaemia development caused by TET2 mutations.